Prof. Kwee Yong, Consultant Haematologist

Prof. Kwee Yong

Consultant Haematologist

Book online
|

Prof. Kwee Yong MA MB BS PhD FRCP FRCPath

Consultant Haematologist

MA MB BS PhD FRCP FRCPath

Prof. Kwee Yong

Consultant Haematologist MA MB BS PhD FRCP FRCPath

Book online
|
MA MB BS PhD FRCP FRCPath
HCA-Healthcare-UK

Areas of expertise

  • Blood diseases (clinical haematology)
  • Myeloma
  • Plasma cell disorders
  • Chemotherapy
HCA-Healthcare-UK

Address

  • HCA UK at University College Hospital

    Grafton Way Building, 1 Grafton Way, London, WC1E 6AG

About Prof. Kwee Yong

GMC number: 2930794

Year qualified: 1984

Place of primary qualification: University of London

Professor Kwee Lan Yong is a specialist in haematological oncology and one of the leading experts in the treatment of patients with multiple myeloma. She completed her medical training at Oxford University and University College London (UCL), before undertaking doctoral studies at UCL. She was awarded a PhD in 1993 for her research into growth factors.

In 1999, Professor Yong was appointed as a Senior Lecturer and Honorary Consultant at UCL. She later became the Clinical and Academic Lead in Multiple Myeloma at University College Hospital and the North London Cancer Network (NLCN).

Professor Yong runs an active trials programme and a laboratory research programme. She has published more than 60 original papers in peer-reviewed journals and serves as a reviewer for international journals and grant-awarding bodies. Additionally, she runs the undergraduate course for haematology at UCL Medical School and regularly speaks at international conferences.

Her areas of expertise include chemotherapy and haematological stem cell transplantation. She is particularly focused on the treatment of myeloma.

Professor Yong has been dedicated to advancing the field of haematological oncology since her appointment in 1999. Her contributions to research, education, and clinical practice have made her a respected figure in her field.

Areas of expertise

  • Lymphomas
  • Thrombosis and embolism
  • Bleeding disorders
  • Multiple myeloma

Professional memberships

National Cancer Research Institute
UK Myeloma Forum
General Medical Council

Articles by Prof. Kwee Yong

Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial

Clinical Features Associated with COVID-19 Outcome in MM: First Results from International Myeloma Society COVID-19 Dataset

Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study

Cell abundance aware deep learning for cell detection on highly imbalanced pathological data

How to Simplify the Evaluation of Newly Introduced Chemotherapeutic Interventions in Myeloma

Multiple Myeloma and Physical Activity